Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Iovance Biotherapeutics (IOVA) Preferred Dividend Payments (2016)

Iovance Biotherapeutics (IOVA) has disclosed Preferred Dividend Payments for 2 consecutive years, with $49.5 million as the latest value for Q3 2016.

  • On a quarterly basis, Preferred Dividend Payments changed N/A to $49.5 million in Q3 2016 year-over-year; TTM through Dec 2018 was $49.5 million, a N/A change, with the full-year FY2016 number at $49.5 million, changed N/A from a year prior.
  • Preferred Dividend Payments was $49.5 million for Q3 2016 at Iovance Biotherapeutics, up from -$8.5 million in the prior quarter.
  • In the past five years, Preferred Dividend Payments ranged from a high of $49.5 million in Q3 2016 to a low of -$8.5 million in Q4 2013.